MONITORING OF IMMUNOGLOBULIN LEVELS IN RA PATIENTS ON ANTI CD20, RITUXIMAB

被引：0
|
作者：
Rice, Ceara [1 ]
Ghandi-Das, Dhivya [1 ]
Negi, Anurag [1 ]
机构：
[1] Univ Hosp Wales, Rheumatol, Cardiff, Wales
来源：
RHEUMATOLOGY | 2020年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P202
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [31] Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia
    Jilani, I
    O'Brien, S
    Manshuri, T
    Thomas, DA
    Thomazy, VA
    Imam, M
    Naeem, S
    Verstovsek, S
    Kantarjian, H
    Giles, F
    Keating, M
    Albitar, M
    BLOOD, 2003, 102 (10) : 3514 - 3520
  • [32] High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, S
    BLOOD, 2004, 104 (11) : 485A - 485A
  • [33] 抗CD20单克隆抗体—Rituximab
    赵江宁
    朱雅丽
    白血病淋巴瘤., 2004, (02) : 123 - 125
  • [34] DYSREGULATED TOTAL SERUM IMMUNOGLOBULIN LEVELS IN PATIENTS WITH RA: RELATIONSHIPS WITH CLINICAL RESPONSE TO RITUXIMAB
    de la Torre, Inmaculada
    Leandro, Maria
    Edwards, Johnathan
    Cambridge, Geraldine
    RHEUMATOLOGY, 2011, 50 : 94 - 94
  • [35] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    BLOOD, 2006, 108 (11) : 155B - 155B
  • [36] Monoclonal anti CD20 antibody rituximab (Mabthera) in the treatment of autoimmune cyclical neutropenia - case report
    Georgievski, B
    Stojanovic, A
    Sijanoski, N
    Cevreska, L
    Stavric, SG
    Stojanoski, Z
    Panovska, I
    Pivkova, A
    Trajkova, S
    Balkanov, S
    Karanfilski, O
    BONE MARROW TRANSPLANTATION, 2005, 35 : S380 - S381
  • [37] Fludarabine synergises with anti CD20 monoclonal antibody Rituximab in complement mediated cell lysis.
    Golay, J
    Xiao, YM
    Di Gaetano, N
    Dastoli, G
    Rambaldi, A
    Introna, M
    BLOOD, 2000, 96 (11) : 339A - 339A
  • [38] Measuring CD20 binding for humanization of anti-CD20 antibody
    Meng, YJG
    Hong, K
    Presta, L
    Penn, A
    Adams, C
    Chuntharapai, A
    Yang, JH
    Lu, YM
    Wong, WL
    FASEB JOURNAL, 2004, 18 (04): : A59 - A59
  • [39] MODULATION OF CD20 ANTIGEN EXPRESSION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AFTER RITUXIMAB THERAPY
    D'Auria, F.
    Guariglia, R.
    Villani, O.
    Pietrantuono, G.
    Martorelli, M.
    Mansueto, G.
    Grieco, V.
    Zonno, A.
    Zifarone, E.
    Bianchino, G.
    Di Giovannantonio, L.
    Vita, G.
    Musto, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 331 - 331
  • [40] Circulating CD52 and CD20 levels predict for progression and survival in patients with CLL treated with fludarabine (F), cyclophosphamide (C), and rituximab (FCR).
    Alatrash, Gheath
    Keating, Michael J.
    O'Brien, Susan
    Wang, Xuemei
    Mahshouri, Taghi
    Faderl, Stefan
    Ferrajoli, Alessadra
    Kantarjan, Hagop M.
    Lemer, Susan
    Wierda, William G.
    BLOOD, 2006, 108 (11) : 660A - 660A
12345